Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Granule associated Rac and RHOG effector 1 (GARRE1) is a human protein encoded by the GARRE1 gene, located on chromosome 19[6]. It is identified by its ability to bind to the CCR4-NOT complex as well as small GTPases and is implicated in Rac protein signal transduction, suggesting a role in intracellular signaling pathways[6][5][3]. GARRE1 is localized to cytoplasmic P-bodies—cellular structures associated with mRNA regulation[6][5][3]. There is no current evidence supporting its role as a direct therapeutic target, nor are there known small-molecule drugs or clinical biomarkers associated with GARRE1. Its main biological activity appears linked to modulation of small GTPase-mediated signaling processes, but its specific physiological and disease-related roles remain poorly characterized in the literature[6][5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granule associated Rac and RHOG effector 1 (GARRE1).